Repligen's Leadership Team

Executive Management

Walter C. Herlihy, Ph.D.
President and Chief Executive Officer

William J. Kelly
Chief Financial Officer

Michael L. Hall, M.D.
Chief Medical Officer
Senior Vice President, Clinical and Regulatory Affairs

Robert A. Spurr
Chief Commercial Officer
Senior Vice President, Sales and Marketing

James R. Rusche, Ph.D.
Senior Vice President, Research and Development

Howard Benjamin, Ph.D.
Vice President, Business Development

Stephen Tingley
Vice President, Bioprocessing Business Development

Laura L. Whitehouse
Vice President, Market Development

Daniel P. Witt, Ph.D.
Vice President, Operations

Board of Directors

Glenn L. Cooper, M.D.
Executive Chairman, Coronado Biosciences

Karen A. Dawes
Co-chairperson, Board of Directors
President, Knowledgeable Decisions, LLC

Alfred L. Goldberg, Ph.D.
Professor of Cell Biology, Harvard Medical School

Earl Webb Henry, M.D.
Managing Director, H2O Clinical, LLC

Walter C. Herlihy, Ph.D.
President and Chief Executive Officer, Repligen Corporation

Alexander Rich, M.D.
Co-Chairman, Board of Directors
Sedgwick Professor of Biophysics, Department of Biology, Massachusetts Institute of Technology

Thomas F. Ryan, Jr.
Retired/Private Investor